David Jasmund

E: djasmund@pcecompanies.com

Follow me: LinkedIn

Largest Transactions Closed

  • Target
  • Buyer
  • Value($mm)
  • Abiomed, Inc.
  • Johnson & Johnson
  • $18,976.96
  • Change Healthcare Inc.
  • Optum, Inc.
  • $13,685.27
  • Biohaven Pharmaceutical Holding Company Ltd.
  • Pfizer Inc.
  • $12,184.48
  • Global Blood Therapeutics, Inc.
  • Pfizer Inc.
  • $5,881.63
  • ChemoCentryx, Inc.
  • Amgen Inc. 
  • $3,972.23
  • Covetrus, Inc.
  • Clayton, Dubilier & Rice, LLC; TPG Capital, L.P.; TPG Global, LLC
  • $3,558.21
  • Biosimilars Portfolio and Related Commercial and Operational Capabilities of Viatris Inc.
  • Biocon Biologics Limited
  • $3,285.00
  • Hanger, Inc.
  • Patient Square Capital, LP
  • $1,397.67
  • Shields Specialty Pharmacy Holdings, LLC
  • Walgreens Boots Alliance, Inc.
  • $1,370.00
  • Magellan Rx Management, LLC
  • Prime Therapeutics, LLC
  • $1,350.00

Other Financial Buyer Transactions Closed

  • Target
  • Buyer
  • Value($mm)
  • Certara, Inc.
  • Arsenal Capital Partners
  • $449.32
  • Etain, LLC
  • RIV Capital Inc. 
  • $246.87
  • Applied Genetic Technologies Corporation
  • Syncona Limited; Syncona Investment Management Limited
  • $93.49

Other Strategic Buyer Transactions Closed

  • Target
  • Buyer
  • Value($mm)
  • Aerie Pharmaceuticals, Inc.
  • Alcon Research, Ltd.
  • $1,090.84
  • Forma Therapeutics Holdings, Inc.
  • Novo Nordisk A/S
  • $1,060.37
  • Rx Savings, LLC
  • McKesson Corporation
  • $875.00

 

Source S&P Capital IQ as of 1/9/2023 and PCE Proprietary Data

New call-to-action

PCE Transactions

Contacts

Michael Poole

Orlando Office

407-621-2112 |

Read More

David Jasmund

Orlando Office

407-621-2111 |

Read More

Data Assumptions

This report represents transaction activity as mergers & acquisitions, consolidations, restructurings and spin-offs. Targets are defined as U.S. Based companies with either foreign or U.S. based buyers. Transaction information provided is based on closed dates only.

Glossary

EBIT - Earnings Before Interest and Taxes
EBITDA - Earnings Before Interest, Taxes, Depreciation, Amortization
LTM - Last Twelve Months
TEV - Total Enterprise Value

Sources:

  1. "2022 Year in Review Infographic: Key Investment Banking Trends." S&P Global Market Intelligence, 19 December 2022.
  2. Wainer, David. "Healthcare Deal-Making Set to Surge in 2023." The Wall Street Journal, 27 December 2022.
  3. Shi, Madeline. "PE continues to snatch up healthcare services companies for roll-up plays" Pitchbook, 28 November 2022.
  4. Mensik, Hailey. "Healthcare leaders expect turbulent operating environment next year." Healthcare Dive, 16 December 2022.
  5. "Johnson & Johnson Completes Acquisition of Abiomed." Johnson & Johnson, 22 December 2022.